Grand Rounds Presentations

Geoffrey Curran, PhD, JD Smith, PhD, Alison Hamilton, PhD | May 27, 2025: Implementation trials frequently run into unanticipated challenges which, if not successfully addressed, can threaten their integrity and derail implementation quality and speed. These problems, and potential solutions, remain largely tacit. In this panel, 4 principal investigators describe how their extramurally-funded implementation trials…

Sara Parent, N.D., K. Michelle Peavy, Ph.D., Kait Hirchak Ph.D. | May 13, 2025: Contingency Management (CM) is an evidence-based behavioral intervention for substance use disorders that is receiving increasing attention as the most effective treatment available for stimulant use disorder. Decades of research have established its efficacy, and more recent Dissemination and Implementation Science…

John Guigayoma, PhD | April 29, 2025 : Black and Latino sexual and gender minorities in the Southern United States have experienced the greatest burden of HIV for the past 25 years. HIV self-testing is an effective strategy to identify individuals living with undiagnosed HIV, but little implementation research is known about which program characteristics…

Fernanda Sequeira Rossi, PhD | May 6, 2025: Dashboards—tools that compile and summarize key performance data—have become increasingly utilized for supporting data organization and decision-making processes across various fields, such as business, economics, healthcare, and policy. The dashboard’s impact is dependent on its use by the individuals for whom it was designed. Yet, few studies…

Ekaterina Burduli, PhD, MS | March 25, 2025: Substance use during pregnancy and parenthood presents significant public health challenges, with potentially severe consequences for mothers and infants with Neonatal Abstinence Syndrome (NAS). Addressing this issue requires innovative, comprehensive interventions and patient-centered approaches to improve care for perinatal women and families impacted by substance use disorders…

Sarah Helseth, PhD | April 1, 2025: Dr. Helseth’s program of research seeks to increase equitable access to and utilization of effective interventions and health services, particularly among underserved populations and high-risk youth. She pursues this objective via several complementary lines of research that span from treatment development and evaluation to widespread dissemination and community-based…

Andrea Jakubowski, MD, MS | April 8, 2025: Over two decades into the opioid overdose crisis, buprenorphine remains underutilized and inaccessible to many people with opioid use disorder. Improving accessibility and utilization requires attention to where treatment is offered and how patients are treated once they enter care. In this presentation, Dr. Jakubowski will describe:…

Tanya Saraiya, PhD | April 22, 2025: Up to 90% of people with opioid use disorder (OUD) have trauma exposure and up to 41% have posttraumatic stress disorder (PTSD). However, studies estimate that less than 12% of people with OUD and co-occurring PTSD receive treatment for their PTSD. Dr. Saraiya will present her early career…

Theresa Matson, PhD, MPH | March 11, 2025: Understanding why some interventions succeed while others fail is crucial for implementing evidence-based practices in real-world settings. Implementation efforts are complex, involving many factors, including the intervention itself, the strategies used to put it into practice, and the unique characteristics of each setting. Traditional research methods provide…

Beth Rutkowski, MPH and Thomas Freese, PhD | March 4, 2025 : Recent evidence indicates that methamphetamine and cocaine play a substantial and increasing role in the illicit drug crisis in the US—the 4th wave of the overdose crisis. The behavioral treatment known as contingency management (CM) has more than three decades of robust research supporting…